Skip to main content
Erschienen in: Pediatric Nephrology 9/2004

01.09.2004 | Original Article

Anemia in pediatric dialysis patients in End-Stage Renal Disease Network 5

verfasst von: Jeffrey J. Fadrowski, Susan L. Furth, Barbara A. Fivush

Erschienen in: Pediatric Nephrology | Ausgabe 9/2004

Einloggen, um Zugang zu erhalten

Abstract

To identify demographic and clinical characteristics associated with failure to achieve hemoglobin levels ≥11 g/dl in prevalent pediatric end-stage renal disease (ESRD) patients, a cross-sectional analysis of patient clinical data collected by the Mid-Atlantic Renal Coalition in conjunction with the 2000 and 2001 ESRD Clinical Performance Measures Projects was performed. Ninety-nine patients (mean age 12.6 years, SD 5.4) contributed 119 observations to this analysis. Of patients on hemodialysis, 36.6% were anemic, and 39.5% of patients on peritoneal dialysis (PD) were anemic. Associations between age, race, gender, assigned cause of ESRD, Kt/V, transferrin saturation, time on dialysis, serum albumin, dialysis modality, and the achievement of target hemoglobin were examined. In multivariate logistic regression analyses examining age, dialysis modality, time on dialysis, and serum albumin, each 1-year increase in age was significantly associated with hemoglobin levels <11 g/dl [adjusted odds ratio (OR) 1.18, 95% confidence interval (CI) 1.06–1.32] and PD patients were more than twice as likely to have hemoglobin levels <11 g/dl (adjusted OR 2.62, 95% CI 0.98–7.04). Patients on dialysis for 6 months or more were less likely to be anemic than those on dialysis for less than 6 months (adjusted OR 0.39, 95% CI 0.16–0.99). In conclusion, increasing age, dialysis for less than 6 months, and treatment with PD were predictive of anemia in this population.
Literatur
1.
Zurück zum Zitat ESRD Clinical Performance Measures Project (2001) 2000 Annual Report. Am J Kidney Dis 37[Suppl 3]:S1–S73 ESRD Clinical Performance Measures Project (2001) 2000 Annual Report. Am J Kidney Dis 37[Suppl 3]:S1–S73
2.
Zurück zum Zitat ESRD Clinical Performance Measures Project (2002) 2001 Annual Report. Am J Kidney Dis 39[Suppl 3]:S4–S98 ESRD Clinical Performance Measures Project (2002) 2001 Annual Report. Am J Kidney Dis 39[Suppl 3]:S4–S98
3.
Zurück zum Zitat Frankenfield DL, Neu AM, Warady BA, Watkins SL, Friedman AL, Fivush BA (2002) Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project. Pediatr Nephrol 17:10–15CrossRefPubMed Frankenfield DL, Neu AM, Warady BA, Watkins SL, Friedman AL, Fivush BA (2002) Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project. Pediatr Nephrol 17:10–15CrossRefPubMed
4.
Zurück zum Zitat Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902CrossRefPubMed Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902CrossRefPubMed
5.
Zurück zum Zitat Chavers BM, Schnaper HW (2001) Risk factors for cardiovascular disease in children on maintenance dialysis. Adv Ren Replace Ther 8:180–190CrossRefPubMed Chavers BM, Schnaper HW (2001) Risk factors for cardiovascular disease in children on maintenance dialysis. Adv Ren Replace Ther 8:180–190CrossRefPubMed
6.
Zurück zum Zitat Stefanidis CJ, Koulieri A, Siapera D, Kapogiannis A, Mitsioni A, Michelis K (1992) Effect of the correction of anemia with recombinant human erythropoietin on growth of children treated with CAPD. Adv Perit Dial 8:460–463PubMed Stefanidis CJ, Koulieri A, Siapera D, Kapogiannis A, Mitsioni A, Michelis K (1992) Effect of the correction of anemia with recombinant human erythropoietin on growth of children treated with CAPD. Adv Perit Dial 8:460–463PubMed
7.
Zurück zum Zitat Baraldi E, Montini G, Zanconato S, Zacchello G, Zacchello F (1990) Exercise tolerance after anemia correction with recombinant human erythropoietin in end-stage renal disease. Pediatr Nephrol 4:623–626PubMed Baraldi E, Montini G, Zanconato S, Zacchello G, Zacchello F (1990) Exercise tolerance after anemia correction with recombinant human erythropoietin in end-stage renal disease. Pediatr Nephrol 4:623–626PubMed
8.
Zurück zum Zitat Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trial Group (1990) The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 263:825–830CrossRefPubMed Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trial Group (1990) The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 263:825–830CrossRefPubMed
9.
Zurück zum Zitat IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]:S182–S238 IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]:S182–S238
10.
Zurück zum Zitat Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61PubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61PubMed
11.
Zurück zum Zitat Steven L, Stigant C, Levin A (2002) Should hemoglobin be normalized in patients with chronic kidney disease? Semin Dial 15:8–13CrossRefPubMed Steven L, Stigant C, Levin A (2002) Should hemoglobin be normalized in patients with chronic kidney disease? Semin Dial 15:8–13CrossRefPubMed
12.
Zurück zum Zitat Schroder CH, The European Pediatric Peritoneal Dialysis Working Group (2003) The management of anemia in pediatric peritoneal dialysis patients. Pediatr Nephrol 18:805–809CrossRefPubMed Schroder CH, The European Pediatric Peritoneal Dialysis Working Group (2003) The management of anemia in pediatric peritoneal dialysis patients. Pediatr Nephrol 18:805–809CrossRefPubMed
13.
Zurück zum Zitat StataCorp (2000) Stata Statistical Software: release 7.0, Stata Corporation, College Station, Texas StataCorp (2000) Stata Statistical Software: release 7.0, Stata Corporation, College Station, Texas
14.
Zurück zum Zitat I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]: S7–S64 I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]: S7–S64
15.
Zurück zum Zitat II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]:S65–S136 II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000 (2001) Am J Kidney Dis 37 [Suppl 1]:S65–S136
16.
Zurück zum Zitat Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, Lawson L, Wilkens K (1993) Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 21:138–144PubMed Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, Lawson L, Wilkens K (1993) Serum albumin concentration-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 21:138–144PubMed
17.
Zurück zum Zitat Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem AS (2003) Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int 64:1120–1124CrossRefPubMed Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem AS (2003) Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int 64:1120–1124CrossRefPubMed
18.
Zurück zum Zitat Matsui DM (1997) Drug compliance in pediatrics. Clinical and research issues. Pediatr Clin North Am 44:1–14PubMed Matsui DM (1997) Drug compliance in pediatrics. Clinical and research issues. Pediatr Clin North Am 44:1–14PubMed
19.
Zurück zum Zitat Tebbi CK (1993) Treatment compliance in childhood and adolescence. Cancer 71 [Suppl]:3441–3449 Tebbi CK (1993) Treatment compliance in childhood and adolescence. Cancer 71 [Suppl]:3441–3449
20.
Zurück zum Zitat Chigier E (1992) Compliance in adolescents with epilepsy or diabetes. J Adolesc Health 13:375–379PubMed Chigier E (1992) Compliance in adolescents with epilepsy or diabetes. J Adolesc Health 13:375–379PubMed
21.
Zurück zum Zitat Meyers KEC, Weiland H, Thomson PD (1992) Paediatric renal transplantation non-compliance. Pediatr Neprol 9:189–192 Meyers KEC, Weiland H, Thomson PD (1992) Paediatric renal transplantation non-compliance. Pediatr Neprol 9:189–192
22.
Zurück zum Zitat Rocco MV, Bedinger MR, Milam R, Greer JW, McClellan WM, Frankenfield DL (2001) Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level. Am J Kidney Dis 38:813–823PubMed Rocco MV, Bedinger MR, Milam R, Greer JW, McClellan WM, Frankenfield DL (2001) Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level. Am J Kidney Dis 38:813–823PubMed
Metadaten
Titel
Anemia in pediatric dialysis patients in End-Stage Renal Disease Network 5
verfasst von
Jeffrey J. Fadrowski
Susan L. Furth
Barbara A. Fivush
Publikationsdatum
01.09.2004
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 9/2004
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1544-7

Weitere Artikel der Ausgabe 9/2004

Pediatric Nephrology 9/2004 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.